303 related articles for article (PubMed ID: 37809324)
1. Fatty infiltration of the pancreas: a systematic concept analysis.
Mahyoub MA; Elhoumed M; Maqul AH; Almezgagi M; Abbas M; Jiao Y; Wang J; Alnaggar M; Zhao P; He S
Front Med (Lausanne); 2023; 10():1227188. PubMed ID: 37809324
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic Fat Infiltration Is Associated with a Higher Risk of Pancreatic Ductal Adenocarcinoma.
Desai V; Patel K; Sheth R; Barlass U; Chan YM; Sclamberg J; Bishehsari F
Visc Med; 2020 Jun; 36(3):220-226. PubMed ID: 32775353
[TBL] [Abstract][Full Text] [Related]
3. Fatty Pancreas-Centered Metabolic Basis of Pancreatic Adenocarcinoma: From Obesity, Diabetes and Pancreatitis to Oncogenesis.
Chang ML
Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327494
[TBL] [Abstract][Full Text] [Related]
4. Fatty pancreas: A possible risk factor for pancreatic cancer in animals and humans.
Takahashi M; Hori M; Ishigamori R; Mutoh M; Imai T; Nakagama H
Cancer Sci; 2018 Oct; 109(10):3013-3023. PubMed ID: 30099827
[TBL] [Abstract][Full Text] [Related]
5. Non-alcoholic fatty pancreas disease.
Alempijevic T; Dragasevic S; Zec S; Popovic D; Milosavljevic T
Postgrad Med J; 2017 Apr; 93(1098):226-230. PubMed ID: 28069746
[TBL] [Abstract][Full Text] [Related]
6. PANCREATIC STEATOSIS: A NEW DIAGNOSIS AND THERAPEUTIC CHALLENGE IN GASTROENTEROLOGY.
Paul J; Shihaz AVH
Arq Gastroenterol; 2020; 57(2):216-220. PubMed ID: 32490903
[TBL] [Abstract][Full Text] [Related]
7. Preoperative CT scan helps to predict the occurrence of severe pancreatic fistula after pancreaticoduodenectomy.
Tranchart H; Gaujoux S; Rebours V; Vullierme MP; Dokmak S; Levy P; Couvelard A; Belghiti J; Sauvanet A
Ann Surg; 2012 Jul; 256(1):139-45. PubMed ID: 22609844
[TBL] [Abstract][Full Text] [Related]
8. [Lipid accumulation in the pancreas: clinical significance of NAFPD (non-alcoholic fatty pancreas disease)].
Jermendy G
Orv Hetil; 2022 Oct; 163(44):1735-1742. PubMed ID: 36309887
[TBL] [Abstract][Full Text] [Related]
9. Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease.
Catanzaro R; Cuffari B; Italia A; Marotta F
World J Gastroenterol; 2016 Sep; 22(34):7660-75. PubMed ID: 27678349
[TBL] [Abstract][Full Text] [Related]
10. Non-Alcoholic Fatty Pancreas Disease (NAFPD): A Silent Spectator or the Fifth Component of Metabolic Syndrome? A Literature Review.
Romana BS; Chela H; Dailey FE; Nassir F; Tahan V
Endocr Metab Immune Disord Drug Targets; 2018; 18(6):547-554. PubMed ID: 29595117
[TBL] [Abstract][Full Text] [Related]
11. Cardio-Metabolic Disease and Polycystic Ovarian Syndrome (PCOS): A Narrative Review.
Sangaraju SL; Yepez D; Grandes XA; Talanki Manjunatha R; Habib S
Cureus; 2022 May; 14(5):e25076. PubMed ID: 35719759
[TBL] [Abstract][Full Text] [Related]
12. Fatty Pancreas: An Underappreciated Intersection of the Metabolic Profile and Pancreatic Adenocarcinoma.
Swislocki A
Metab Syndr Relat Disord; 2021 Aug; 19(6):317-324. PubMed ID: 33656378
[TBL] [Abstract][Full Text] [Related]
13. Fatty Pancreas: Disease or Finding?
Silva LLSE; Fernandes MSS; Lima EA; Stefano JT; Oliveira CP; Jukemura J
Clinics (Sao Paulo); 2021; 76():e2439. PubMed ID: 33624707
[TBL] [Abstract][Full Text] [Related]
14. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
Jeanes YM; Reeves S
Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
[TBL] [Abstract][Full Text] [Related]
15. Non-alcoholic fatty pancreas disease - practices for clinicians.
Pinte L; Balaban DV; Băicuş C; Jinga M
Rom J Intern Med; 2019 Sep; 57(3):209-219. PubMed ID: 30901317
[TBL] [Abstract][Full Text] [Related]
16. Diabetes mellitus does not impact on clinically relevant pancreatic fistula after partial pancreatic resection for ductal adenocarcinoma.
Malleo G; Mazzarella F; Malpaga A; Marchegiani G; Salvia R; Bassi C; Butturini G
Surgery; 2013 May; 153(5):641-50. PubMed ID: 23276391
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic fatty degeneration and fibrosis as predisposing factors for the development of pancreatic ductal adenocarcinoma.
Tomita Y; Azuma K; Nonaka Y; Kamada Y; Tomoeda M; Kishida M; Tanemura M; Miyoshi E
Pancreas; 2014 Oct; 43(7):1032-41. PubMed ID: 24991971
[TBL] [Abstract][Full Text] [Related]
18. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
Teede HJ; Tay CT; Laven JJE; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; Redman LM; Boyle JA; Norman RJ; Mousa A; Joham AE
J Clin Endocrinol Metab; 2023 Sep; 108(10):2447-2469. PubMed ID: 37580314
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, "Prediabetes," Diabetes and Atherosclerosis.
Filippatos TD; Alexakis K; Mavrikaki V; Mikhailidis DP
Dig Dis Sci; 2022 Jan; 67(1):26-41. PubMed ID: 33469809
[TBL] [Abstract][Full Text] [Related]
20. Comorbidities and complications of polycystic ovary syndrome: An overview of systematic reviews.
Gilbert EW; Tay CT; Hiam DS; Teede HJ; Moran LJ
Clin Endocrinol (Oxf); 2018 Dec; 89(6):683-699. PubMed ID: 30099747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
